Skip to main content

Want a detailed portfolio tracker?

OverviewPerformanceMetricsFinancialsIndustryCorrelations
Market CapEPSP/EP/SP/BSharesProfit MarginOperating MarginDebt to EquityRevenueEarningsEBITDAFree Cash FlowTotal DebtTotal AssetsROAROE

Revance Therapeutics (RVNC) Debt to Equity (2014 - 2024)

Revance Therapeutics (RVNC) debt to equity from Mar 31, 2014 to Sep 30, 2024. The current Revance Therapeutics (RVNC) debt to equity is -271.13%. You can export chart.

Debt to Equity

Debt to Equity

Annual Debt to Equity change of Revance Therapeutics (RVNC)

YearDebt to EquityChange
2023-284.80%
-109.44%
20223016.19%
+635.88%
2021409.87%
+749.78%
202048.23%
N/A
20190.00%
N/A
20180.00%
-100.00%
20170.70%
-76.98%
20163.02%
-9.77%
20153.35%
+66.83%
20142.01%
N/A

Comparison Revance Therapeutics (RVNC) debt to equity with competitors

Revance Therapeutics (RVNC) debt to equity is -271.13%.

TickerNameDebt to EquityUpside
DRUGBright Minds Biosciences Inc0.03%-100.01%
CMNDClearmind Medicine Inc0.10%-100.04%
ARVNArvinas Inc0.13%-100.05%
GHRSGH Research PLC0.16%-100.06%
ATHEAlterity Therapeutics Ltd0.18%-100.07%
CGONCg Oncology Inc0.27%-100.10%
PHVSPharvaris NV0.31%-100.12%
OSRHBellevue Life Sciences Acquisition Corp0.37%-100.14%
GLPGGalapagos NV0.37%-100.14%
VTVTvTv Therapeutics Inc - Class A0.46%-100.17%
LPTXLeap Therapeutics Inc0.68%-100.25%
ADXNAddex Therapeutics Ltd0.73%-100.27%
CBUSCibus Global Ltd. Class A0.75%-100.28%
ABVCABVC BioPharma Inc0.82%-100.30%
COEPCoeptis Therapeutics Holdings Inc. Common Stock0.87%-100.32%
PPCBPropanc Biopharma Inc1.05%-100.39%
ARGXArgen X SE1.14%-100.42%
OCSOculis Holding AG1.14%-100.42%
XRTXXORTX Therapeutics Inc1.17%-100.43%
IMMPImmutep Ltd1.22%-100.45%
CANFCan-Fite Biopharma Ltd1.27%-100.47%
BNTXBioNTech SE1.62%-100.60%
NBPNovaBridge Biosciences.1.74%-100.64%
NRXSNeuraxis Inc1.75%-100.65%
IMABI-Mab1.77%-100.65%
IFRXInflaRx N.V.2.23%-100.82%
ENTOEntero Therapeutics, Inc. Common Stock2.51%-100.93%
GANXGain Therapeutics Inc2.67%-100.98%
NCNANuCana plc3.04%-101.12%
SXTP60 Degrees Pharmaceuticals Inc3.29%-101.21%
IMTXImmatics N.V3.31%-101.22%
YMABY-Mabs Therapeutics Inc3.66%-101.35%
IRONDisc Medicine Inc4.27%-101.57%
BDRXBiodexa Pharmaceuticals Plc4.38%-101.62%
SVASinovac Biotech Ltd4.55%-101.68%
LGVNLongeveron Inc - Class A4.67%-101.72%
MOLNMolecular Partners AG4.89%-101.80%
NCELNLS Pharmaceutics Ltd4.90%-101.81%
ADAGAdagene Inc5.23%-101.93%
PRTCPureTech Health plc American Depositary Shares5.56%-102.05%
ALXOAlx Oncology Holdings Inc5.62%-102.07%
REGNRegeneron Pharmaceuticals Inc6.32%-102.33%
ANROAlto Neuroscience Inc6.58%-102.43%
MDXGMimedx Group Inc7.24%-102.67%
GDTCCytoMed Therapeutics Ltd7.37%-102.72%
MRNAModerna Inc7.96%-102.94%
QLGNQualigen Therapeutics, Inc. Common Stock8.40%-103.10%
BEAMBeam Therapeutics Inc8.60%-103.17%
PBYIPuma Biotechnology Inc8.79%-103.24%
PYPDPolypid Ltd9.00%-103.32%
KURAKura Oncology Inc9.04%-103.33%
SLNOSoleno Therapeutics Inc10.06%-103.71%
VRAXVirax Biolabs Group Ltd - Class A10.13%-103.74%
RIGLRigel Pharmaceuticals11.25%-104.15%
MAZEMaze Therapeutics Inc11.36%-104.19%
ABEOAbeona Therapeutics Inc12.48%-104.60%
CLDICalidi Biotherapeutics Inc12.62%-104.66%
ASBPAspire Biopharma Holdings Inc12.90%-104.76%
ACIUAC Immune SA13.65%-105.03%
MNMDMind Medicine (MindMed) Inc. Common Shares14.62%-105.39%
VERAVera Therapeutics Inc - Class A15.01%-105.54%
ALTAltimmune Inc15.25%-105.62%
NUVBNuvation Bio Inc - Class A16.62%-106.13%
SVRASavara Inc17.08%-106.30%
ACHVAchieve Life Sciences Inc17.21%-106.35%
DYNDyne Therapeutics Inc17.27%-106.37%
HRMYHarmony Biosciences Holdings Inc17.45%-106.43%
SPRBSpruce Biosciences Inc18.66%-106.88%
RCUSArcus Biosciences Inc19.08%-107.04%
INVAInnoviva Inc19.24%-107.10%
MDWDMediWound Ltd19.62%-107.24%
TARSTarsus Pharmaceuticals Inc20.80%-107.67%
XNCRXencor Inc21.05%-107.76%
MESOMesoblast Ltd21.45%-107.91%
TCRXTscan Therapeutics Inc22.51%-108.30%
APLSApellis Pharmaceuticals Inc22.59%-108.33%
REPLReplimune Group Inc22.62%-108.34%
CNTACentessa Pharmaceuticals plc22.66%-108.36%
BMRNBiomarin Pharmaceutical Inc23.02%-108.49%
TSHATaysha Gene Therapies Inc23.10%-108.52%
FBIOFortress Biotech Inc23.12%-108.53%
HYFTMindWalk Holdings Corp23.71%-108.75%
ONCBeiGene Ltd24.13%-108.90%
LXRXLexicon Pharmaceuticals Inc24.49%-109.03%
NKTRNektar Therapeutics24.89%-109.18%
ICCCImmucell Corp29.87%-111.02%
CRSPCRISPR Therapeutics AG32.27%-111.90%
ZLABZai Lab Ltd32.30%-111.91%
QUREuniQure N.V.33.44%-112.33%
ABOSAcumen Pharmaceuticals Inc35.49%-113.09%
ALDXAldeyra Therapeutics Inc36.29%-113.39%
PRQRProQR Therapeutics N.V36.40%-113.43%
OBIOOrchestra BioMed Holdings Inc36.41%-113.43%
COGTCogent Biosciences Inc36.72%-113.54%
ELABPMGC Holdings Inc37.62%-113.87%
MLTXMoonLake Immunotherapeutics - Class A38.98%-114.38%
LEGNLegend Biotech Corp40.23%-114.84%
PHXMPHAXIAM Therapeutics SA ADR42.62%-115.72%
PHARPharming Group N.V.43.21%-115.94%
XFORX4 Pharmaceuticals Inc44.52%-116.42%
ADMAAdma Biologics Inc50.44%-118.60%
SRPTSarepta Therapeutics Inc55.69%-120.54%
BLRXBioline Rx Ltd55.78%-120.57%
ARQTArcutis Biotherapeutics Inc57.70%-121.28%
MDGLMadrigal Pharmaceuticals Inc62.62%-123.10%
CAICaris Life Sciences Inc - Class A64.29%-123.71%
SRRKScholar Rock Holding Corp71.23%-126.27%
INSMInsmed Inc76.93%-128.37%
ATAIATAI Life Sciences N.V.83.95%-130.96%
VRNAVerona Pharma Plc87.12%-132.13%
IONSIonis Pharmaceuticals Inc88.01%-132.46%
RYTMRhythm Pharmaceuticals Inc88.25%-132.55%
RPRXRoyalty Pharma plc - Class A90.13%-133.24%
CDXSCodexis Inc93.64%-134.54%
ALECAlector Inc94.08%-134.70%
GMABGenmab94.17%-134.73%
TTRXTurn Therapeutics Inc97.04%-135.79%
GERNGeron Corp109.92%-140.54%
XOMAXOMA Corp110.73%-140.84%
HCWBHCW Biologics Inc114.14%-142.10%
JAZZJazz Pharmaceuticals plc118.15%-143.57%
MRVIMaravai LifeSciences Holdings Inc - Class A119.30%-144.00%
TLXTelix Pharmaceuticals Ltd126.06%-146.50%
TGTXTG Therapeutics Inc127.78%-147.13%
ARDXArdelyx Inc136.94%-150.50%
FOLDAmicus Therapeutics Inc143.18%-152.81%
QNTMFSD Pharma Inc - Class B - Class B (Sub Voting)146.17%-153.91%
AAPGAscentage Pharma Group International149.47%-155.13%
OPTOpthea Ltd156.18%-157.60%
SPRYARS Pharmaceuticals Inc157.44%-158.07%
NMRANeumora Therapeutics Inc159.82%-158.95%
MISTMilestone Pharmaceuticals Inc161.42%-159.54%
CLLSCellectis181.25%-166.85%
ASNDAscendis Pharma A/S183.75%-167.77%
FTREFORTE SOFTWARE INC200.32%-173.88%
CELCCelcuity Inc257.58%-195.00%
HOWLWerewolf Therapeutics Inc262.95%-196.98%
VALNValneva SE273.15%-200.74%
ALLRAllarity Therapeutics Inc290.17%-207.02%
HUMAHumacyte Inc308.59%-213.82%
AXSMAxsome Therapeutics Inc344.13%-226.92%
ADAPAdaptimmune Therapeutics plc American Depositary Shares423.98%-256.37%
PGENPrecigen Inc462.16%-270.46%
OCGNOcugen Inc502.91%-285.48%
SNDXSyndax Pharmaceuticals Inc840.90%-410.14%
HALOHalozyme Therapeutics Inc976.45%-460.14%
EDITEditas Medicine Inc1240.40%-557.49%
IOBTIO Biotech Inc1829.20%-774.65%